CY1110702T1 - Anthelmintic Composition - Google Patents

Anthelmintic Composition

Info

Publication number
CY1110702T1
CY1110702T1 CY20101100668T CY101100668T CY1110702T1 CY 1110702 T1 CY1110702 T1 CY 1110702T1 CY 20101100668 T CY20101100668 T CY 20101100668T CY 101100668 T CY101100668 T CY 101100668T CY 1110702 T1 CY1110702 T1 CY 1110702T1
Authority
CY
Cyprus
Prior art keywords
anthelmintic composition
anthelmintic
composition
xanthomycin
triclabendazole
Prior art date
Application number
CY20101100668T
Other languages
Greek (el)
Inventor
James S Rowe
Jon C Hayes
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05706144A external-priority patent/EP1713468B9/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of CY1110702T1 publication Critical patent/CY1110702T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μια ανθελμινθική σύνθεση η οποία περιλαμβάνει μια αβερμεκτίνη ή μιλβεμυκίνη, μαζί με τρικλαβενδαζόλη, και μια προκαθορισμένη ποσότητα τροποποιητή ρεολογίας, όπως το Laponite ή το ξανθογονικό κόμμι, επαρκή για να καθίσταται η ανθελμινθική σύνθεση κατάλληλη ως στοματικό πότημα.The present invention provides an anthelmintic composition comprising an avermectin or milbemycin, together with triclabendazole, and a predetermined amount of rheology modifier, such as Laponite or xanthomycin, sufficient to make the anthelmintic composition suitable.

CY20101100668T 2004-02-03 2010-07-16 Anthelmintic Composition CY1110702T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54147204P 2004-02-03 2004-02-03
EP05706144A EP1713468B9 (en) 2004-02-03 2005-02-01 Anthelmintic composition

Publications (1)

Publication Number Publication Date
CY1110702T1 true CY1110702T1 (en) 2015-06-10

Family

ID=42664702

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100668T CY1110702T1 (en) 2004-02-03 2010-07-16 Anthelmintic Composition

Country Status (1)

Country Link
CY (1) CY1110702T1 (en)

Similar Documents

Publication Publication Date Title
CY1112781T1 (en) 2'-FLUORO-2'-DEOXYTETRAHYROIDURIDES AS CYTIDINE DISEASE INHIBITORS
CY1119534T1 (en) Phosphorus derivatives as kinase inhibitors
CY1117990T1 (en) 5-AZAKITIDINE FORMS
CR8402A (en) INDAZOL-O-GLUCOSIDS SUBSTITUTES
CY1110602T1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF GEL OR SOLUTION BASED ON DIABROSTEOSTERONE, METHODS OF PREPARATION AND USES
CY1114504T1 (en) TIGECYCLINE COMPOSITIONS AND PREPARATION METHODS
NO20060202L (en) Pyrrolodihydroisoquinolines as PDE-10 inhibitors
CY1108092T1 (en) UNIONS AND METHODS FOR SUSPENSION OF AURORA CHINESE PROHIBITION
CR10530A (en) ANTI-DLLA4 ANTIBODIES AND METHODS THAT USE THEM
ATE528989T1 (en) CRYSTALLINE SOLID RASAGILIN BASE
ECSP066822A (en) MACRÓLIDOS AND METHODS TO PRODUCE THE SAME
CY1110753T1 (en) INHIBITIONS OF 11-BETA-HYDROXYSTEROID dehydrogenation I
GT200600148A (en) METHODS FOR THE TREATMENT AND PREVENTION OF FIBROSIS
CY1113907T1 (en) Bicyclic heteroaryl compounds
GT200500238A (en) SUBSTITUTED PHENYLAMINOTIAZOLS AND ITS USE
PA8667201A1 (en) NEW PHARMACEUTICAL COMPOUNDS
UY29518A1 (en) DERIVATIVES OF RENT-, ALQUENIL- AND ALQUINILCARBAMATOS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS.
CY1115847T1 (en) USE OF TYLVALOSIN AS ANTIQUE FACTOR
PA8792401A1 (en) PHENILENDIAMINS
DK1713468T3 (en) Anthelmintic composition
DOP2009000214A (en) ERYTHROMYCIN-BASED MACROLIDS
CY1110702T1 (en) Anthelmintic Composition
BRPI0417205A (en) pharmaceutical compositions
CY1114113T1 (en) COMBINATION OF A VASCULAR IF VASCULAR INHIBITOR AND A BETA-INHIBITOR
FR2907121B1 (en) NEW MORPHINIC DERIVATIVES